Search Results - "Kamat, Shivani S."

Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19 by Bommakanti, Nikhil K, Zhou, Yunshu, Ehrlich, Joshua R, Elam, Angela R, John, Denise, Kamat, Shivani S, Kelstrom, Jared, Newman-Casey, Paula Anne, Shah, Manjool M, Weizer, Jennifer S, Wood, Sarah D, Zhang, Amy D, Zhang, Jason, Lee, Paul P, Stein, Joshua D

“…During the coronavirus disease 2019 (COVID-19) pandemic, eye care professionals caring for patients with sight-threatening diseases, such as glaucoma, have had…”
Get more information

Novel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort by Prasov, Lev, Guan, Bin, Ullah, Ehsan, Archer, Steven M., Ayres, Bernadete M., Besirli, Cagri G., Wiinikka-Buesser, Laurel, Comer, Grant M., Del Monte, Monte A., Elner, Susan G., Garnai, Sarah J., Huryn, Laryssa A., Johnson, Kayla, Kamat, Shivani S., Lieu, Philip, Mian, Shahzad I., Rygiel, Christine A., Serpen, Jasmine Y., Pawar, Hemant S., Brooks, Brian P., Moroi, Sayoko E., Richards, Julia E., Hufnagel, Robert B.

“…Nanophthalmos is a rare condition defined by a small, structurally normal eye with resultant high hyperopia. While six genes have been implicated in this…”
Get full text

The Ability of Nitric Oxide to Lower Intraocular Pressure Is Dependent on Guanylyl Cyclase by Muenster, Stefan, Lieb, Wolfgang S, Fabry, Gregor, Allen, Kaitlin N, Kamat, Shivani S, Guy, Ann H, Dordea, Ana C, Teixeira, Leandro, Tainsh, Robert E, Yu, Binglan, Zhu, Wei, Ashpole, Nicole E, Malhotra, Rajeev, Brouckaert, Peter, Bloch, Donald B, Scherrer-Crosbie, Marielle, Stamer, W Daniel, Kuehn, Markus H, Pasquale, Louis R, Buys, Emmanuel S

“…While nitric oxide (NO) donors are emerging as treatments for glaucoma, the mechanism by which NO lowers intraocular pressure (IOP) is unclear. NO activates…”
Get full text

The Role of the Immune System in Glaucoma: Bridging the Divide Between Immune Mechanisms in Experimental Glaucoma and the Human Disease by Kamat, Shivani S., Gregory, Meredith S., Pasquale, Louis R.

“…Glaucoma is one of the leading causes of visual impairment worldwide. Classically, clinicians have evaluated patients through a full ophthalmological…”
Get full text

Integrating Patient Education Into the Glaucoma Clinical Encounter: A Lean Analysis by Newman-Casey, Paula A, Musser, John A, Niziol, Leslie M, Heisler, Michele M, Kamat, Shivani S, Shah, Manjool M, Patel, Nish, Cohn, Amy M

“…PURPOSE:The main purpose of this study was to use Lean analysis to identify how often and when wait times occur during a glaucoma visit to identify…”
Get full text

The Appropriateness of Digital Diabetic Retinopathy Screening Images for a Computer-Aided Glaucoma Screening System by Almazroa, Ahmed A, Woodward, Maria A, Newman-Casey, Paula Anne, Shah, Manjool M, Elam, Angela R, Kamat, Shivani S, Karvonen-Gutierrez, Carrie A, Wood, Sarah D, Kumar, Navasuja, Moroi, Sayoko E

“…The purpose of this study was to evaluate the ability to screen for glaucoma using a Food Drug Administration (FDA) Class II diagnostic digital fundus…”
Get full text